A Phase 2 Study of Firi-cel in Patients With Relapsed/Refractory Large B-cell Lymphoma

New York University Medical Center, New York

Roswell Park Comprehensive Cancer Center, Buffalo

University of Pennsylvania, Philadelphia

Thomas Jefferson University, Philadelphia

National Cancer Institute, Bethesda

University of Maryland Medical Center, Baltimore

Northside Hospital, Atlanta

University of Miami Hospital Sylvester Comprehensive Cancer Center, Miami

Vanderbilt University Medical Center, Nashville

The Ohio State University Comprehensive Cancer Center, Columbus

Cleveland Clinic Foundation, Cleveland

University of Michigan Rogel Cancer Center, Ann Arbor

University of Iowa Hopitals & Clinics, Iowa City

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

University of Chicago Medical Center, Chicago

Washington University School of Medicine in St. Louis, St Louis

University of Kansas Medical Center Research Institute, Inc, Westwood

University of Arkansas Medical Sciences, Little Rock

MD Anderson Cancer Center, Houston

Colorado Blood Cancer Institute, Denver

UCLA Division of Hematology Oncology, Los Angeles

City of Hope National Medical Center, Duarte

Stanford University Hospital and Clinics, Stanford

Swedish Medical Center, Seattle

UW-Fred Hutchinson Cancer Center, Seattle

Yale University, New Haven

H. Lee Moffitt Cancer Center and Research Institute, Tampa

Beth Israel Deaconess Medical Center, Boston

Dana-Farber Cancer Institute, Boston

UT Southwestern Medical Center, Dallas

Medical College of Wisconsin, Milwaukee